Comparative study on heparin and a synthetic thrombin inhibitor no. 805 (MD-805*) in experimental antithrombin III-deficient animals.
D000208:Acute Disease; D000818:Animals; D000888:Antibodies, Anti-Idiotypic; D000941:Antigens; D000990:Antithrombin III / Q000276:immunology; D001120:Arginine / Q000031:analogs & derivatives; D001780:Blood Coagulation Tests; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010875:Pipecolic Acids / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D013449:Sulfonamides; D013917:Thrombin; D013924:Thrombophlebitis / Q000188:drug therapy* / Q000209:etiology
D000888:Antibodies, Anti-Idiotypic; D000941:Antigens; D005343:Fibrinolytic Agents; D010875:Pipecolic Acids; D013449:Sulfonamides; D000990:Antithrombin III; D006493:Heparin; D001120:Arginine; D013917:Thrombin; C031942:argatroban